Clinical Trial: RSV Immunisation Status in Queensland (Australia)

U.S., May 30 -- ClinicalTrials.gov registry received information related to the study (NCT07615192) titled 'RSV Immunisation Status in Queensland (Australia)' on May 22.

Brief Summary: The primary objective of this study is to determine the nirsevimab immunisation rate in eligible infants (according to Queensland Paediatric Respiratory Syncytial Virus Prevention Program recommendation) in Queensland, Australia.

The study will focus on:

1. Assessing the immunisation rates among eligible infants (born from 1 February 2024 to 15 April 2025) in their first Respiratory Syncytial Virus (RSV)-season in Queensland.

Secondary objectives of this study are as follows:

1. To analyse reasons of parents to decide for or against immunisation of their...